Performance

INBX +13.69%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
INBX	+8.54%	+16.13%	+13.69%	—	-49.39%	0.51	0.00%

Summary

INBX at a glance

INBX returned +13.69% over the past year. Its worst drop in that year was -49.39%, smaller than 23% of stocks on Redstone, and its Sharpe ratio of 0.51 beats 51% of stocks on Redstone. It pays no dividends.

Ranking

How INBX ranks

Current Drawdown

-35.32%

Rolling Volatility

117.15%

Actions

Metrics

Risk Indicators

Alpha21.49%

Beta2.09x

Sharpe0.51

Sortino0.80

Omega1.10

Calmar0.28

Martin1.61

Profile

About INBX

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms.

Sector: Health Care
Industry: Biological Products, (no Diagnostic Substances)
Market cap: $1.4B
Listed: May 2024
Employees: 110
Headquarters: La Jolla, CA
Website: inhibrx.com

Comparisons

INBX: Inhibrx Biosciences, Inc.

INBX at a glance

How INBX ranks

Current Drawdown

Rolling Volatility

About INBX

Related comparisons